Home
Protalix Biotherapeutics, Inc.

Protalix Biotherapeutics... Market Share Analysis for May 2026

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

Health > Biotechnology and Pharmaceuticals

Domainprotalix.com

Year Founded1992

Employees201 - 500

Annual Revenue$50M - $75M

Protalix Biotherapeutics, Inc.

Protalix Biotherapeutics, Inc. (including company regionals)

protalix.com

See more website traffic and engagement information

Protalix Biotherapeutics, Inc. Revenue up to May 2026 is 50M - 75M

revenue generated by Protalix Biotherapeutics, Inc. top domains

Protalix Biotherapeutics, Inc. top domains revenue over 3 years

Revenue for Protalix Biotherapeutics, Inc. top domains

protalix.com50M - 75M

See more with Sales Intelligence

Total visits to Protalix Biotherapeutics, Inc.'s top domains

Understand Protalix Biotherapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

protalix.com6K

See more with Sales Intelligence

Avg. visit duration in Protalix Biotherapeutics, Inc.'s top domains

Analyze Protalix Biotherapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

protalix.com00:00:18

See more with Sales Intelligence

Avg. pageviews on Protalix Biotherapeutics, Inc.'s top domains

See how Protalix Biotherapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

protalix.com1.83

See more with Sales Intelligence

Protalix Biotherapeutics, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Protalix Biotherapeutics, Inc.

These are the website technologies, by industry, used by Protalix Biotherapeutics, Inc. top domains

Payment & Currencies (6)

Cart Functionality

Conversion & Analytics (4)

Google Analytics

Widget (3)

Google Maps

Content Management System (2)

WordPress

More Technologies

7

See all

News & Signals from Protalix Biotherapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsProtalix Biotherapeutics Inc. integrates with Secarna Pharmaceuticals GmbH & Co. KG.Partnership combines Protalix's rare disease and biologics expertise with Secarna's AI - powered OligoCreator(R) platform to jointly develop pharmaceutical candidates for rare renal indications

NewsProtalix Biotherapeutics Inc. partnered with Chiesi Group on Jun 21st '18.Protalix has partnered with Chiesi Farmaceutici S.p.A. for the global development and commercialization of Elfabrio.